Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Cai-Fang Ni"'
Publikováno v:
Asian Journal of Surgery, Vol 47, Iss 3, Pp 1626-1627 (2024)
Externí odkaz:
https://doaj.org/article/7f9e750e33494125bf2f721872d23869
Publikováno v:
BMC Cardiovascular Disorders, Vol 20, Iss 1, Pp 1-7 (2020)
Abstract Background To detect the right atrial (RA) functions in hypertrophic cardiomyopathy (HCM) patients by using volume-derived values and two-dimensional strain. Methods Thirty-two HCM patients and 34 age and gender matched normal controls were
Externí odkaz:
https://doaj.org/article/460f7b7d5c67406e957674e4de427f1a
Autor:
Qiang Li, Lei Zhang, Zhong-Heng Hou, Dong-Xu Zhao, Jian-Bin Li, Shuai Zhang, Yu Yin, Cai-Fang Ni, Tao Chen
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Objectives: This study aimed to evaluate the association between different body composition features with prognostic outcomes of intermediate stage hepatocellular carcinoma (HCC) patients treated with transarterial chemoembolization (TACE).Methods: T
Externí odkaz:
https://doaj.org/article/afb4aa085c204183978b4dfa9d7e0d0b
Autor:
Lei Zhang, Zhi-Ping Yan, Zhong-Heng Hou, Peng Huang, Min-Jie Yang, Shuai Zhang, Shen Zhang, Shao-Hua Zhang, Xiao-Li Zhu, Cai-Fang Ni, Qiang Li
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2021)
Externí odkaz:
https://doaj.org/article/3b354231cd764dbf8c6339233b78d4af
Autor:
Zhi-Cheng Jin, Li Chen, Bin-Yan Zhong, Hai-Dong Zhu, Chu-Hui Zeng, Rui Li, Jin-He Guo, Shi-Cheng He, Gang Deng, Xiao-Li Zhu, Cai-Fang Ni, Gao-Jun Teng
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
PurposeGiven that the novel coronavirus disease (COVID-19) pandemic has disrupted operations globally, an institution’s ability to repeat transarterial chemoembolization (TACE) for patients with hepatocellular carcinoma (HCC) has also been affected
Externí odkaz:
https://doaj.org/article/cb2cf17f753f4ad28436abff5eebac16
Autor:
Bin-Yan Zhong, Zhi-Ping Yan, Jun-Hui Sun, Lei Zhang, Zhong-Heng Hou, Xiao-Li Zhu, Ling Wen, Cai-Fang Ni
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2021)
Objectives: To use baseline variables to predict one-year disease control for patients with hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE) combined with sorafenib as initial treatment by applying a machine learning
Externí odkaz:
https://doaj.org/article/c18a8c91fca24278b9333e6f9d90c9ff
Autor:
Lei Zhang, Zhi-Ping Yan, Zhong-Heng Hou, Peng Huang, Min-Jie Yang, Shuai Zhang, Shen Zhang, Shao-Hua Zhang, Xiao-Li Zhu, Cai-Fang Ni, Qiang Li
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2021)
Objectives: To investigate the predictive value of inflammatory biomarkers in patients with unresectable hepatocellular carcinoma (HCC) for outcomes following the combination treatment of transarterial chemoembolization (TACE) plus sorafenib.Material
Externí odkaz:
https://doaj.org/article/02ea274f84b1479f8971f0c930e3bcde
Autor:
Li Chen, Chen-Xi Yu, Bin-Yan Zhong, Hai-Dong Zhu, Zhi-Cheng Jin, Guang-Yu Zhu, Qi Zhang, Cai-Fang Ni, Gao-Jun Teng
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2021)
Purpose: To identify the independent risk factors for transarterial embolization (TACE) refractoriness and to develop a novel TACE refractoriness score and nomogram for predicting TACE refractoriness in patients with hepatocellular carcinoma (HCC).Me
Externí odkaz:
https://doaj.org/article/6441a458e73a47fb80bb268fbf1759b3
Autor:
Bin-Yan Zhong, Zhi-Ping Yan, Jun-Hui Sun, Lei Zhang, Zhong-Heng Hou, Min-Jie Yang, Guan-Hui Zhou, Wan-Sheng Wang, Zhi Li, Peng Huang, Shen Zhang, Xiao-Li Zhu, Cai-Fang Ni
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
PurposeTo establish albumin-bilirubin (ALBI) grade-based and Child-Turcotte-Pugh (CTP) grade-based nomograms, as well as to develop an artificial neural network (ANN) model to compare the prognostic performance and discrimination of these two grades
Externí odkaz:
https://doaj.org/article/2f583820831e48d9957d5c98d33b2cce
Autor:
Lei Zhang, Wei Xia, Zhi-Ping Yan, Jun-Hui Sun, Bin-Yan Zhong, Zhong-Heng Hou, Min-Jie Yang, Guan-Hui Zhou, Wan-Sheng Wang, Xing-Yu Zhao, Jun-Ming Jian, Peng Huang, Rui Zhang, Shen Zhang, Jia-Yi Zhang, Zhi Li, Xiao-Li Zhu, Xin Gao, Cai-Fang Ni
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
ObjectivesTo develop and validate a deep learning-based overall survival (OS) prediction model in patients with hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE) plus sorafenib.MethodsThis retrospective multicenter st
Externí odkaz:
https://doaj.org/article/07a96a5dc8244156a7042b776ce4a5ca